| Literature DB >> 33980226 |
Peter A Jacobsen1,2, Alex J van 't Hul3, Remco S Djamin4, Jeanine C Antons3, Marianne de Man5, Ulla Møller Weinreich6,7, Martijn A Spruit8,9,10, Daisy J A Janssen8,11.
Abstract
INTRODUCTION: Patients with COPD are vulnerable to workforce detachment. Better knowledge of features associated with paid work loss might be of help to design and select appropriate interventions.Entities:
Keywords: Chronic Obstructive Pulmonary Disease (COPD); Occupation; Workforce connection
Mesh:
Year: 2021 PMID: 33980226 PMCID: PMC8117298 DOI: 10.1186/s12931-021-01736-6
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Fig. 1Flow chart of included patients. Abbreviations: Chronic obstructive pulmonary disease (COPD), forced expiratory volume in one second (FEV1), forced vital capacity (FVC)
Demographics of population on workforce connection
| Variable | Level | Total (n = 404) | Paid work (n = 213) | No paid work (n = 191) | |
|---|---|---|---|---|---|
| Age (years) | Median [iqr] | 58 [53, 61] | 57 [52, 60] | 58 [54.5, 62.0] | < 0.01 |
| Age group | < 50 years | 46 (11.4) | 32 (15.0) | 14 (7.3) | |
| 50–54 years | 76 (18.8) | 42 (19.7) | 34 (17.8) | ||
| 55–59 years | 138 (34.2) | 70 (32.9) | 68 (35.6) | 0.072 | |
| 60–64 years | 144 (35.6) | 69 (32.4) | 75 (39.3) | ||
| Sex | Female | 211 (52.2) | 103 (48.4) | 108 (56.5) | 0.122 |
| Educational level | Low | 245 (60.6) | 118 (55.4) | 127 (66.5) | |
| Medium /High | 159 (39.4) | 95 (44.6) | 64 (33.5) | 0.039 | |
| Smoking status | Never smoker | 9 (2.2) | 6 (2.8) | 3 (1.6) | |
| Active smoker | 214 (53.0) | 104 (48.8) | 110 (57.6) | ||
| Previous smoker | 181 (44.8) | 103 (48.4) | 78 (40.8) | 0.180 | |
| Smoking history (years)π | Median [iqr] | 40 [30, 43] | 38 [30, 40] | 40 [32, 45] | 0.085 |
| FEV1% predicted | Mean (sd) | 55.9 (18.8) | 58.5 (18.5) | 52.9 (18.8) | < 0.01 |
| FVC% predicted | Mean (sd) | 91.9 (17) | 94.9 (17.2) | 88.5 (16.2) | < 0.01 |
| FEV1%/FVC% | Mean (sd) | 0.5 (0.1) | 0.5 (0.1) | 0.5 (0.1) | 0.151 |
| FEV1% predicted | < 30 | 46 (11.4) | 28 (13.1) | 18 (9.4) | |
| 30–59 | 190 (47.0) | 113 (53.1) | 77 (40.3) | ||
| 50–79 | 143 (35.4) | 63 (29.6) | 80 (41.9) | ||
| ≥ 80 | 25 (6.2) | 9 (4.2) | 16 (8.4) | < 0.01 | |
| Height | Mean (sd) | 170.1 (9.1) | 171.4 (8.8) | 168.7 (9.1) | < 0.01 |
| Weight | Median [iqr] | 71 [60, 85] | 71 [61, 85] | 71 [59, 86] | 0.475 |
| BMI (kg/m2) | Median [iqr] | 24.8 [21.5, 28.6] | 24.4 [21.8, 27.8] | 25.3 [21.1, 29.0] | 0.579 |
| BMI | < 21 kg/m2 | 88 (21.8) | 40 (18.8) | 48 (25.1) | |
| 21–30 kg/m2 | 242 (59.9) | 137 (64.3) | 105 (55.0) | ||
| > 30 kg/m2 | 74 (18.3) | 36 (16.9) | 38 (19.9) | 0.148 | |
| Abnormal BMI | < 21 or > 30 kg/m2 | 162 (40.1) | 76 (35.7) | 86 (45.0) | 0.070 |
| Exacerbations previous year€ | 0–1 Exacerbations | 243 (70.2) | 145 (76.3) | 98 (62.8) | |
| ≥ 2 Exacerbation | 103 (29.8) | 45 (23.7) | 58 (37.2) | < 0.01 | |
| Steps per day | < 5000 | 151 (37.4) | 57 (26.8) | 94 (49.2) | < 0.01 |
| 6MWD predicted | < 70% | 203 (50.2) | 83 (39.0) | 120 (62.8) | < 0.01 |
| MRCα | 1 | 99 (26.5) | 59 (29.8) | 40 (22.9) | |
| 2 | 116 (31.1) | 72 (36.4) | 44 (25.1) | ||
| 3 | 92 (24.7) | 42 (21.2) | 50 (28.6) | ||
| 4 | 42 (11.3) | 17 (8.6) | 25 (14.3) | ||
| 5 | 24 (6.4) | 8 (4.0) | 16 (9.1) | < 0.01 | |
| MRCα | ≥ 3 | 158 (42.4) | 67 (33.8) | 91 (52.0) | < 0.01 |
| CIS pointsΩ | Mean (sd) | 37.3 (12.5) | 36.2 (12.3) | 38.7 (12.7) | 0.080 |
| CISΩ | ≥ 36 points | 180 (58.4) | 86 (52.8) | 94 (64.8) | 0.042 |
| Comorbidities | |||||
| Arterial hypertension# | 30 (23.3) | 14 (21.5) | 16 (25.0) | 0.797 | |
| Coronary artery disease# | 9 (7.0) | 4 (6.2) | 5 (7.8) | 0.981 | |
| Heart attack# | 8 (6.2) | 4 (6.2) | 4 (6.2) | 1.000 | |
| Heart rhythm disturbance# | 4 (3.1) | 2 (3.1) | 2 (3.1) | 1.000 | |
| Cerebral infarction# | 6 (4.7) | 2 (3.1) | 4 (6.2) | 0.662 | |
| Chronic heart failure# | 4 (3.1) | 2 (3.1) | 2 (3.1) | 1.000 | |
| Peripheral vascular disease# | 7 (5.4) | 3 (4.6) | 4 (6.2) | 0.983 | |
| Anemia# | 1 (0.8) | 0 (0.0) | 1 (1.6) | 0.994 | |
| Diabetes# | 9 (7.0) | 5 (7.7) | 4 (6.2) | 1.000 | |
| Chronic renal failure# | 3 (2.3) | 1 (1.5) | 2 (3.1) | 0.989 | |
| Osteoporosis# | 8 (6.2) | 5 (7.7) | 3 (4.7) | 0.732 | |
| Skeletal muscle dysfunction / muscle weakness# | 1 (0.8) | 0 (0.0) | 1 (1.6) | 0.994 | |
| Arthrosis# | 13 (10.1) | 5 (7.7) | 8 (12.5) | 0.539 | |
| Depression# | 13 (10.1) | 4 (6.2) | 9 (14.1) | 0.230 | |
| Anxiety# | 7 (5.4) | 3 (4.6) | 4 (6.2) | 0.983 | |
| Cognitive impairment# | 1 (0.8) | 1 (1.5) | 0 (0.0) | 1.000 | |
| Gastroesophageal reflux# | 6 (4.7) | 2 (3.1) | 4 (6.2) | 0.662 | |
| Obstructive sleep apnea# | 2 (1.6) | 2 (3.1) | 0 (0.0) | 0.483 | |
| Cancer# | 4 (3.1) | 0 (0.0) | 4 (6.2) | 0.124 | |
| Comorbidity count# | 0 | 29 (22.5) | 20 (30.8) | 9 (14.1) | |
| 1 | 48 (37.2) | 20 (30.8) | 28 (43.8) | ||
| 2 + | 52 (40.3) | 25 (38.5) | 27 (42.2) | 0.062 | |
Forced vital capacity (FVC), Forced expiratory volume in one second (FEV1), Standard deviation (sd), Interquartile range (IQR), Body mass index (BMI), Medical research council dyspnea score (MRC)
Missing data: πn = 108, $n = 95, §n = 97, &n = 107, €n = 58, αn = 31, Ωn = 96, Ⅎn = 17, ∂n = 23, #n = 275
Fig. 2Logistic regression model exploring treatable traits related with not being in paid work. Red model: *OR of model including only confounders. Missing data for specific treatable traits are shown in Na column. †OR of treatable traits adjusted for age, sex, FEV1% and educational level. Blue model: Including all confounders * and treatable traits † in the same model. Due to missing data across different treatable traits 150 patients were excluded from blue analysis leaving 254 with complete data. Odds Ratio (OR), Confidence Interval (CI), standard deviation (sd), Interquartile range (IQR), Forced Expiratory Volume in one second (FEV1), Medical Research Council (MRC score), Body Mass Index (BMI), Checklist Individual Strength (CIS), 6 min walk distance (6MWD).